S. Panigone

Most-cited papers

1. ATM protein and p53-serine 15 phosphorylation in ataxia-telangiectasia (AT) patients and at heterozygotes

   Domenico Delia, S. Mizutani, S. Panigone, E. Tagliabue +9 more

   2000British Journal of Cancer57 citations Open access

   Semantic Scholar

   Save

2. pRb and Cdk regulation by N-(4-hydroxyphenyl)retinamide

   S. Panigone, S. Debernardi, Y. Taya, E. Fontanella +2 more

   2000Oncogene35 citations

   Semantic Scholar

   Save

3. Lutetium-177-labeled gastrin releasing peptide receptor binding analogs: a novel approach to radionuclide therapy.

   S. Panigone, A. Nunn

   2006The Quarterly Journal of Nuclear Medicine and Molecular Imaging24 citations

   Semantic Scholar

   Save

4. Up‐regulation of prosaposin by the retinoid HPR and the effect on ceramide production and integrin receptors

   S. Panigone, Roberta Bergomas, E. Fontanella, A. Prinetti +3 more

   2001The FASEB Journal23 citations

   Semantic Scholar

   Save

5. SOM3355: a unique pharmacological profile combining VMAT1 inhibition, VMAT2-mediated dopamine modulation, and β1-adrenergic antagonism for the treatment of movement and neuropsychiatric disorders

   E. S. Turilli-Ghisolfi, S. I. Støve, O. Huertas, Trond-André Kråkenes +3 more

   2026Frontiers in Pharmacology1 citations Open access

   Semantic Scholar

   Save

6. Safety and efficacy of SOM3355 in patients with Huntington’s disease (SOMCT03): a phase 2b, randomised, placebo-controlled, multicentre, dose-ranging study

   J. Kulisevsky, D. Craufurd, Jan Lewerenz, C. Scaglione +6 more

   2026EClinicalMedicine0 citations Open access

   Semantic Scholar

   Save

7. The BLACKSWAN Foundation for rare diseases

   O. Menzel, S. Panigone

   20170 citations

   Semantic Scholar

   Save